Glucotrack: White Lion reports 9.99% stake

Rhea-AI Filing Summary

Glucotrack, Inc. (GCTK) is reported to have its common stock beneficially owned by White Lion Capital LLC, which reports beneficial ownership of 79,734 shares, representing 9.99% of the common stock outstanding, calculated under Rule 13d-3 as if certain ownership limits were 9.99%. White Lion directly owns 77,492 shares and may acquire additional shares under a stock purchase agreement, a senior convertible promissory note, commitment share warrants and other warrants, all subject to contractual ownership limitations that generally cap actual holdings at about 4.9–4.99% unless increased upon notice.

Key Figures

Beneficially owned shares (Rule 13d-3 basis): 79,734 shares Reported beneficial ownership percentage: 9.99% Shares held directly: 77,492 shares +4 more

7 metrics

Beneficially owned shares (Rule 13d-3 basis) 79,734 shares Shares of Glucotrack common stock beneficially owned by White Lion Capital LLC for Schedule 13G purposes

Reported beneficial ownership percentage 9.99% Percentage of Glucotrack common stock beneficially owned by White Lion Capital LLC

Shares held directly 77,492 shares Glucotrack common shares directly owned by White Lion Capital LLC as of the filing date

Shares outstanding 798,144 shares Glucotrack common stock outstanding as of August 28, 2026, used for ownership calculation

Sole voting power 79,734 shares Shares over which White Lion Capital LLC has sole voting power

Sole dispositive power 79,734 shares Shares over which White Lion Capital LLC has sole dispositive power

Ownership cap under Note and similar instruments 4.9–4.99%, with option up to 9.9–9.99% Ownership limitations that restrict additional share acquisitions absent written notice

Key Terms

Rule 13d-3, senior convertible promissory note, beneficial ownership, Ownership Limitations, +1 more

5 terms

Rule 13d-3 regulatory

"Solely for the purposes of Rule 13d-3 and this , White Lion is filing"

Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.

senior convertible promissory note financial

"a senior convertible promissory note (the "Note")"

beneficial ownership financial

"would result in the beneficial ownership by the Fund and its affiliates"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Ownership Limitations financial

"the "Ownership Limitations")"

Ownership limitations are rules or contract terms that cap how much of a company any single investor or group can hold, whether set by law, a company’s governing documents, or shareholder agreements. They matter to investors because they can limit voting power, affect whether a buyer can take control, influence stock demand and liquidity, and create compliance risks—similar to a speed limit that constrains how fast any one driver can go on a road.

commitment share common warrants financial

"commitment share common warrants ("Common Warrants")"

FAQ

What percentage of Glucotrack, Inc. (GCTK) does White Lion Capital LLC report owning?

White Lion Capital LLC reports beneficial ownership of 79,734 shares, equal to 9.99% of Glucotrack’s common stock, calculated under Rule 13d-3 based on 798,144 shares outstanding as of August 28, 2026.

How many Glucotrack (GCTK) shares does White Lion Capital LLC currently hold directly?

White Lion Capital LLC directly holds 77,492 shares of Glucotrack common stock as of the filing date. The higher reported beneficial amount reflects potential shares issuable under financing agreements, assuming ownership limits of 9.99% for Rule 13d-3 calculations.

What is the Glucotrack (GCTK) share count used for White Lion’s 13G calculation?

The reported 9.99% beneficial ownership is calculated using 798,144 shares of Glucotrack common stock outstanding as of August 28, 2026, in accordance with Rule 13d-3 under the Exchange Act.

What agreements give White Lion Capital LLC additional exposure to Glucotrack (GCTK)?

White Lion’s potential Glucotrack exposure comes from a Stock Purchase Agreement, a Securities Purchase Agreement, a senior convertible promissory note, Common Warrants, SPA Warrants, and Abeyance Shares, each allowing share acquisition subject to specified ownership limitations.

What ownership caps apply to White Lion’s Glucotrack (GCTK) instruments?

White Lion is generally limited to about 4.9–4.99% beneficial ownership under the Common Warrants, SPA Warrants, Note, and Purchase Agreement, but may elect to increase those limits up to 9.9–9.99% with prior written notice to Glucotrack.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 06:16 PM Accepted by SEC EDGAR 09/02/2026 - 06:15 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Glucotrack, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

45824Q887

(CUSIP Number)

08/26/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 45824Q887

1

Names of Reporting Persons

White Lion Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEVADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 79,734.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 79,734.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

79,734.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: (1) The shares of common stock (the "Shares") of Glucotrack, Inc. (the "Issuer") reported herein represent (i) 77,492 Shares held by White Lion Capital LLC ("White Lion"), and (ii) additional Shares that may be acquired by White Lion pursuant to (a) a common stock purchase agreement (the "Stock Purchase Agreement") with an effective date of July 14, 2026, between the Issuer and White Lion, as amended pursuant to the Amendment No. 1 to the Stock Purchase Agreement (the "Amendment"), (b) commitment shares held in abeyance ("Abeyance Shares"), (c) commitment share common warrants ("Common Warrants"), (d) a securities purchase agreement (the "Securities Purchase Agreement"), (e) a senior convertible promissory note (the "Note"), and (f) common share warrants issued pursuant to the Securities Purchase Agreement (the "SPA Warrants"). Under the Common Warrants, the Note, and the SPA Warrants, White Lion may acquire Shares (or securities convertible into or exercisable for Shares) in accordance with the respective terms and subject to the respective conditions and limitations contained therein. One of such limitations is that White Lion is prohibited from acquiring any Shares under the Common Warrants, which, when aggregated with all other Shares then beneficially owned by White Lion and its affiliates, would result in the beneficial ownership by the Fund and its affiliates to exceed 4.99% of the Shares outstanding (the "Common Warrant Ownership Limitation"). White Lion may increase the Common Warrant Ownership Limitation up to 9.99% upon sixty-one (61) days prior written notice to the Issuer. Another limitation is that White Lion is prohibited from acquiring any Shares under the Note which, when aggregated with all other Shares then beneficially owned by White Lion and its affiliates, would result in the beneficial ownership by the Fund and its affiliates to exceed 4.9% of the Shares outstanding (the "Note Ownership Limitation"). White Lion may increase the Note Ownership Limitation up to 9.9% upon written notice to the Issuer. Another limitation is that White Lion is prohibited from acquiring any Shares under the SPA Warrants, which, when aggregated with all other Shares then beneficially owned by White Lion and its affiliates, would result in the beneficial ownership by the Fund and its affiliates to exceed 4.99% of the Shares outstanding (the "SPA Warrant Ownership Limitation"). White Lion may increase the SPA Warrant Ownership Limitation up to 9.99% upon sixty-one (61) days prior written notice to the Issuer. Furthermore, under the Stock Purchase Agreement, at the Issuer's sole discretion, White Lion may be required to purchase Shares, in accordance with the terms and subject to the conditions and limitations of the Purchase Agreement. One of such limitations is that the Fund is prohibited from acquiring any Shares under the Purchase Agreement, which, when aggregated with all other Shares then beneficially owned by the Fund and its affiliates, would result in the beneficial ownership by the Fund and its affiliates to exceed 4.99% of the Shares outstanding (the "Purchase Agreement Ownership Limitation" and together with the Common Warrant Ownership Limitation, the Note Ownership Limitation, and the SPA Warrant Limitation, the "Ownership Limitations"). For the sake of clarity, White Lion owns 77,492 Shares as of the date of the filing and currently has no right to acquire Shares currently held in abeyance or upon exercise of outstanding Common Warrants, and Note as of the date of the filing due to the Ownership Limitations. Solely for the purposes of Rule 13d-3 and this Schedule 13G, White Lion is filing this report to reflect that it may beneficially own Shares pursuant to the Stock Purchase Agreement, Common Warrants, Note, and SPA Warrants as if the Ownership Limitations were 9.99% even if, in the future, it ceases to hold the Shares it currently holds. The filing of this report shall not be deemed an admission, for purposes of Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose. (2) Calculated in accordance with Rule 13d-3 promulgated under the Exchange Act and based on 798,144 shares of Common Stock outstanding as of August 28, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Glucotrack, Inc.
(b)	Address of issuer's principal executive offices: 301 RT 17 NORTH, SUITE 800, RUTHERFORD, NJ, 07070
Item 2.
(a)	Name of person filing: White Lion Capital LLC
(b)	Address or principal business office or, if none, residence: 17631 Ventura Blvd., Suite 1008 Encino, California 91316
(c)	Citizenship: Nevada
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 45824Q887
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnote thereto, is incorporated by reference in this Item 4.
(b)	Percent of class: The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnote thereto, is incorporated by reference in this Item 4.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnote thereto, is incorporated by reference in this Item 4.
	(ii) Shared power to vote or to direct the vote: The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnote thereto, is incorporated by reference in this Item 4.
	(iii) Sole power to dispose or to direct the disposition of: The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnote thereto, is incorporated by reference in this Item 4.
	(iv) Shared power to dispose or to direct the disposition of: The information contained in rows 5 through and including row 11 on the cover page of this Schedule 13G, including the footnote thereto, is incorporated by reference in this Item 4.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

White Lion Capital LLC

Signature:	/s/ Yash Thukral
Name/Title:	Yash Thukral, Managing Partner
Date:	09/02/2026